Comparative genomic hybridization detects genetic alterations during early stages of cervical cancer progression
β Scribed by Kenji Umayahara; Fumitaka Numa; Yutaka Suehiro; Aki Sakata; Shugo Nawata; Hidenobu Ogata; Yoshinori Suminami; Masaru Sakamoto; Kohsuke Sasaki; Hiroshi Kato
- Book ID
- 102219851
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 98 KB
- Volume
- 33
- Category
- Article
- ISSN
- 1045-2257
- DOI
- 10.1002/gcc.1215
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Invasive cervical carcinoma is thought to arise from cervical intraepithelial neoplasm (CIN). Genetic changes that occur during progression of CIN to cervical carcinoma are poorly understood, although they appear to be directly involved in this process. We used comparative genomic hybridization (CGH) with precise microdissection and degenerate oligonucleotide primedβpolymerase chain reaction (DOPβPCR) to detect genetic alterations in normal epithelial, CIN, and invasive carcinoma tissues colocalized in tumors from 18 patients with squamous cell carcinoma of the uterine cervix. Gains on chromosome 1 and on 3q and losses on 2q, 3p, 4, 6p, 11q, and 17p were frequent alterations found in CIN and invasive carcinoma lesions. Interestingly, several of these genetic changes were observed in preinvasive carcinoma lesions. The frequency and average number of genetic alterations corresponded directly to the extent to which the cervical carcinoma had progressed. Frequent alterations were found in more than 90% of CIN III lesions. Gains on 3q and losses on 11q were the most prevalent genetic alterations found in association with uterine cervix carcinogenesis. The common regions of alteration were 3q26.1βq28 and 11q23βqter. The majority of tumor samples showed variability in genetic alterations across lesion types within a single specimen.
π SIMILAR VOLUMES
## Abstract Copy number increase of 8q has previously been shown to be associated with a poor clinical outcome and tumor recurrence in patients with prostate cancer. In this study, a detailed genomic analysis of 8q was performed of archival primary and metastatic prostatic adenocarcinomas (__n__ =